{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:34:25Z","timestamp":1786624465684,"version":"build-2736575974"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41569-026-01323-6","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:47:54Z","timestamp":1784288874000},"page":"615-616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The renaissance of cardiac glycosides in heart failure: why, for whom and when"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7609-6297","authenticated-orcid":false,"given":"Antonio","family":"Cannata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-9602","authenticated-orcid":false,"given":"Theresa A.","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"1323_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0002-9149(88)90947-2","volume":"61","author":"GH Guyatt","year":"1988","unstructured":"Guyatt, G. H. et al. A controlled trial of digoxin in congestive heart failure. Am. J. Cardiol. 61, 371\u2013375 (1988).","journal-title":"Am. J. Cardiol."},{"key":"1323_CR2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM198203253061202","volume":"306","author":"DC Lee","year":"1982","unstructured":"Lee, D. C. et al. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N. Engl. J. Med. 306, 699\u2013705 (1982).","journal-title":"N. Engl. J. Med."},{"key":"1323_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM199702203360801","volume":"336","author":"Digitalis Investigation Group","year":"1997","unstructured":"Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N. Engl. J. Med. 336, 525\u2013533 (1997).","journal-title":"N. Engl. J. Med."},{"key":"1323_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/eurheartj\/ehi687","volume":"27","author":"A Ahmed","year":"2006","unstructured":"Ahmed, A. et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur. Heart J. 27, 178\u2013186 (2006).","journal-title":"Eur. Heart J."},{"key":"1323_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jchf.2024.06.013","volume":"13","author":"A Cannata","year":"2025","unstructured":"Cannata, A. et al. Heart failure specialist care and long-term outcomes for patients admitted with acute heart failure. JACC Heart Fail. 13, 402\u2013413 (2025).","journal-title":"JACC Heart Fail."},{"key":"1323_CR6","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.jacc.2025.12.025","volume":"87","author":"A Cannata","year":"2026","unstructured":"Cannata, A. et al. Ethnicity and heart failure outcomes in England: role of specialist care in a universal health system. J. Am. Coll. Cardiol. 87, 1235\u20131256 (2026).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1323_CR7","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1056\/NEJMoa2415471","volume":"393","author":"U Bavendiek","year":"2025","unstructured":"Bavendiek, U. et al. Digitoxin in patients with heart failure and reduced ejection fraction. N. Engl. J. Med. 393, 1155\u20131165 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1323_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-026-04406-6","author":"DJ van Veldhuisen","year":"2026","unstructured":"van Veldhuisen, D. J. et al. Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-026-04406-6 (2026).","journal-title":"Nat. Med."},{"key":"1323_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehag385","author":"P van der Meer","year":"2026","unstructured":"van der Meer, P. et al. Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehag385 (2026).","journal-title":"Eur Heart J."},{"key":"1323_CR10","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1001\/jama.2026.7886","volume":"335","author":"K Damman","year":"2026","unstructured":"Damman, K. et al. Efficacy and safety of digitalis glycosides in heart failure: a meta-analysis. JAMA 335, 2029\u20132037 (2026).","journal-title":"JAMA"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01323-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01323-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01323-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:01:36Z","timestamp":1786622496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01323-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1323"],"URL":"https:\/\/doi.org\/10.1038\/s41569-026-01323-6","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"17 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.A.M. declares no competing interests.\u00a0A.C. is\u00a0supported by the King\u2019s Health Partners Centre for Translational Medicine. The views expressed are those of the authors\u00a0and not necessarily those of King\u2019s Health Partners.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}